GLIOBLASTOMAS (GBM)

Clinical trials for GLIOBLASTOMAS (GBM) explained in plain language.

Never miss a new study

Get alerted when new GLIOBLASTOMAS (GBM) trials appear

Sign up with your email to follow new studies for GLIOBLASTOMAS (GBM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Experimental drug combo targets tough brain cancers

Disease control Completed

This early-phase trial tested a new drug called obitazidine (SM-1) combined with the chemotherapy temozolomide in 35 adults with recurrent high-grade gliomas, a type of aggressive brain cancer. The main goal was to find a safe dose and check for side effects, while also looking f…

Matched conditions: GLIOBLASTOMAS (GBM)

Phase: PHASE1 • Sponsor: Shenzhen Zhenxing Medical Technology Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC

GLIOBLASTOMAS (GBM)

Get alerted when new GLIOBLASTOMAS (GBM) trials appear

Experimental drug combo targets tough brain cancers